Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$209.01 - $232.56 $14,003 - $15,581
67 Added 0.02%
300,777 $65.7 Million
Q4 2023

Feb 13, 2024

SELL
$197.69 - $227.29 $127,114 - $146,147
-643 Reduced 0.21%
300,710 $68.3 Million
Q3 2023

Nov 14, 2023

BUY
$201.05 - $221.7 $319,870 - $352,724
1,591 Added 0.53%
301,353 $60.6 Million
Q1 2023

May 15, 2023

SELL
$213.32 - $257.83 $1.13 Million - $1.37 Million
-5,315 Reduced 1.74%
299,762 $68.8 Million
Q4 2022

Feb 14, 2023

SELL
$203.72 - $248.97 $893,515 - $1.09 Million
-4,386 Reduced 1.42%
305,077 $71.8 Million
Q3 2022

Nov 16, 2022

SELL
$204.81 - $262.19 $953,390 - $1.22 Million
-4,655 Reduced 1.48%
309,463 $63.4 Million
Q2 2022

Aug 15, 2022

SELL
$213.86 - $277.87 $396,710 - $515,448
-1,855 Reduced 0.59%
314,118 $73.6 Million
Q1 2022

May 16, 2022

BUY
$259.82 - $298.18 $713,725 - $819,100
2,747 Added 0.88%
315,973 $83.3 Million
Q4 2021

Feb 15, 2022

SELL
$271.6 - $314.21 $160,244 - $185,383
-590 Reduced 0.19%
313,226 $98.4 Million
Q3 2021

Nov 15, 2021

SELL
$274.82 - $308.34 $849,743 - $953,387
-3,092 Reduced 0.98%
313,816 $88.3 Million
Q2 2021

Aug 16, 2021

SELL
$251.87 - $278.14 $211,318 - $233,359
-839 Reduced 0.26%
316,908 $87.4 Million
Q1 2021

May 18, 2021

SELL
$204.88 - $255.03 $927,286 - $1.15 Million
-4,526 Reduced 1.4%
317,747 $81 Million
Q4 2020

Feb 16, 2021

SELL
$186.91 - $214.42 $557,739 - $639,829
-2,984 Reduced 0.92%
322,273 $65.6 Million
Q3 2020

Nov 16, 2020

SELL
$167.03 - $201.3 $336,565 - $405,619
-2,015 Reduced 0.62%
325,257 $61.2 Million
Q2 2020

Aug 14, 2020

BUY
$113.31 - $182.44 $19,376 - $31,197
171 Added 0.05%
327,272 $54.4 Million
Q4 2019

Feb 12, 2020

SELL
$163.48 - $173.61 $1.47 Million - $1.57 Million
-9,018 Reduced 2.68%
327,101 $55.3 Million
Q3 2019

Nov 14, 2019

BUY
$159.77 - $178.1 $732,705 - $816,766
4,586 Added 1.38%
336,119 $56.5 Million
Q2 2019

Aug 13, 2019

BUY
$144.16 - $172.9 $529,788 - $635,407
3,675 Added 1.12%
331,533 $57.3 Million
Q1 2019

May 14, 2019

BUY
$123.7 - $156.3 $5.07 Million - $6.4 Million
40,976 Added 14.28%
327,858 $50.2 Million
Q4 2018

Feb 14, 2019

SELL
$120.82 - $174.09 $2.75 Million - $3.97 Million
-22,778 Reduced 7.36%
286,882 $36.2 Million
Q3 2018

Nov 15, 2018

SELL
$167.67 - $188.27 $9,221 - $10,354
-55 Reduced 0.02%
309,660 $53.8 Million
Q2 2018

Aug 15, 2018

BUY
$160.33 - $189.41 $8.2 Million - $9.69 Million
51,133 Added 19.77%
309,715 $55.6 Million
Q4 2017

Feb 15, 2018

BUY
$147.99 - $163.95 $3.4 Million - $3.76 Million
22,942 Added 9.74%
258,582 $41.2 Million
Q3 2017

Nov 14, 2017

BUY
$149.47 - $160.56 $35.2 Million - $37.8 Million
235,640
235,640 $0

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.4B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.